Richard B. Gallagher

Last updated
Richard Gallagher
Richard Gallagher.jpg
NationalityScottish
CitizenshipUnited Kingdom [1]
Education University of Glasgow (B.S., PhD)
Scientific career
FieldsImmunology
Institutions
Thesis Studies on cell adhesion in relation to immune responses
Doctoral advisor Adam S. G. Curtis

Richard Barclay Gallagher is a Scottish immunologist, science editor, and academic publisher. He is the president and editor-in-chief of Annual Reviews. He graduated with a doctoral degree from the University of Glasgow and was a researcher at Trinity College Dublin before he began working in academic publishing in 1989, holding positions with Elsevier and the journals Science and Nature . In the 2000s, he was the editor of the magazine The Scientist . In 2015, he became president and editor-in-chief of Annual Reviews, where he oversaw the expansion into new journal titles, launched its first online magazine Knowable Magazine, and developed the Subscribe to Open initiative for open access publishing.

Contents

Education

Richard Barclay Gallagher received a Bachelor of Science in immunology from the University of Glasgow in 1981. [2] He earned a PhD in cell biology, also at the University of Glasgow, in 1985 under the advisorship of Adam S. G. Curtis. [1] [3] While a PhD student, he joined the British Society for Immunology. [4] He was later a postdoctoral fellow at University College Dublin, where he researched sarcoidosis. [1]

Career

From 1986 to 1989, Richard Gallagher worked as the Wellcome Trust Lecturer in Immunology at Trinity College Dublin. In 1989, he left academic research and began a career in publishing, [1] becoming editor of the magazine Immunology Today , published by Elsevier, until 1992. From 1992 to 1999, he was office head and senior editor of the Europe Office of the journal Science . He was the chief biology editor at the journal Nature from 1999 to 2001, during which time he managed the publication of the papers reporting the sequencing of the human genome, and served as the publisher of Nature from 2001 to 2002. [2]

In 2002, he was hired as editor of the magazine The Scientist  ; he additionally became its publisher in 2004. [5] [6] During his tenure, he shifted the format from biweekly to monthly; its style changed from a "quirky tabloid" to a "stylish and engaging magazine". [7] He published monthly editorials about topics such as vaccines, [8] the longevity of punishment for scientific misconduct, [9] and whether or not intelligent design should be taught in public schools. [10] He worked at The Scientist for eight years, leaving in 2010. [11]

In 2015, he became editor-in-chief and president of Annual Reviews, succeeding Samuel Gubins. [12] He also serves on the Board of Directors of Annual Reviews. [13] While at Annual Reviews, he developed the "Subscribe to Open" initiative to remove paywalls from its review journals. [14] Several new journal titles were added to Annual Reviews since his tenure began, including in cancer biology; biomedical data science; control, robotics, and autonomous systems; criminology; and developmental psychology. [15] He also developed and launched Knowable Magazine, the first webzine published by Annual Reviews, which is written for a general audience. [16]

Works

Related Research Articles

<i>Nature</i> (journal) British scientific journal

Nature is a British weekly scientific journal founded and based in London, England. As a multidisciplinary publication, Nature features peer-reviewed research from a variety of academic disciplines, mainly in science and technology. It has core editorial offices across the United States, continental Europe, and Asia under the international scientific publishing company Springer Nature. Nature was one of the world's most cited scientific journals by the Science Edition of the 2022 Journal Citation Reports, making it one of the world's most-read and most prestigious academic journals. As of 2012, it claimed an online readership of about three million unique readers per month.

<span class="mw-page-title-main">PLOS</span> Nonprofit open-access publisher

PLOS is a nonprofit publisher of open-access journals in science, technology, and medicine and other scientific literature, under an open-content license. It was founded in 2000 and launched its first journal, PLOS Biology, in October 2003.

<i>Science</i> (journal) Academic journal of the American Association for the Advancement of Science

Science is the peer-reviewed academic journal of the American Association for the Advancement of Science (AAAS) and one of the world's top academic journals. It was first published in 1880, is currently circulated weekly and has a subscriber base of around 130,000. Because institutional subscriptions and online access serve a larger audience, its estimated readership is over 400,000 people.

<span class="mw-page-title-main">Academic publishing</span> Subfield of publishing distributing academic research and scholarship

Academic publishing is the subfield of publishing which distributes academic research and scholarship. Most academic work is published in academic journal articles, books or theses. The part of academic written output that is not formally published but merely printed up or posted on the Internet is often called "grey literature". Most scientific and scholarly journals, and many academic and scholarly books, though not all, are based on some form of peer review or editorial refereeing to qualify texts for publication. Peer review quality and selectivity standards vary greatly from journal to journal, publisher to publisher, and field to field.

<span class="mw-page-title-main">Elsevier</span> Dutch publishing and analytics company

Elsevier is a Dutch academic publishing company specializing in scientific, technical, and medical content. Its products include journals such as The Lancet, Cell, the ScienceDirect collection of electronic journals, Trends, the Current Opinion series, the online citation database Scopus, the SciVal tool for measuring research performance, the ClinicalKey search engine for clinicians, and the ClinicalPath evidence-based cancer care service. Elsevier's products and services include digital tools for data management, instruction, research analytics, and assessment. Elsevier is part of the RELX Group, known until 2015 as Reed Elsevier, a publicly traded company. According to RELX reports, in 2022 Elsevier published more than 600,000 articles annually in over 2,800 journals; as of 2018 its archives contained over 17 million documents and 40,000 e-books, with over one billion annual downloads.

Nature Portfolio is a division of the international scientific publishing company Springer Nature that publishes academic journals, magazines, online databases, and services in science and medicine.

<i>Cell</i> (journal) Scientific journal

Cell is a peer-reviewed scientific journal publishing research papers across a broad range of disciplines within the life sciences. Areas covered include molecular biology, cell biology, systems biology, stem cells, developmental biology, genetics and genomics, proteomics, cancer research, immunology, neuroscience, structural biology, microbiology, virology, physiology, biophysics, and computational biology. The journal was established in 1974 by Benjamin Lewin and is published twice monthly by Cell Press, owned by Elsevier.

Annual Reviews is an independent, non-profit academic publishing company based in San Mateo, California. As of 2021, it publishes 51 journals of review articles and Knowable Magazine, covering the fields of life, biomedical, physical, and social sciences. Review articles are usually "peer-invited" solicited submissions, often planned one to two years in advance, which go through a peer-review process. The organizational structure has three levels: a volunteer board of directors, editorial committees of experts for each journal, and paid employees.

Human Immunology is a monthly peer-reviewed medical journal published by Elsevier in behalf of the American Society for Histocompatibility and Immunogenetics. It contains original research articles, review articles, and brief communications on the subjects of immunogenetics, cellular immunology and immune regulation, and clinical immunology. The journal was established in 1980, and has been published monthly since 1983. The journal has had five editors-in-chief: Bernard Amos (1980–1996), Nicole Suciu-Foca (1997–2013), Steven Mack (2014–2016), Amy Hahn (2016–2022), and James Matthew (2023–present).

Scholarly peer review or academic peer review is the process of having a draft version of a researcher's methods and findings reviewed by experts in the same field. Peer review is widely used for helping the academic publisher decide whether the work should be accepted, considered acceptable with revisions, or rejected for official publication in an academic journal, a monograph or in the proceedings of an academic conference. If the identities of authors are not revealed to each other, the procedure is called dual-anonymous peer review.

<span class="mw-page-title-main">The Cost of Knowledge</span> Protest movement against research publishing house Elsevier and for open science

The Cost of Knowledge is a protest by academics against the business practices of academic journal publisher Elsevier. Among the reasons for the protests were a call for lower prices for journals and to promote increased open access to information. The main work of the project was to ask researchers to sign a statement committing not to support Elsevier journals by publishing, performing peer review, or providing editorial services for these journals.

Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram. Frontiers is based in Lausanne, Switzerland, with offices in the United Kingdom, Spain, and China. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.

ResearchGate is a European commercial social networking site for scientists and researchers to share papers, ask and answer questions, and find collaborators. According to a 2014 study by Nature and a 2016 article in Times Higher Education, it is the largest academic social network in terms of active users, although other services have more registered users, and a 2015–2016 survey suggests that almost as many academics have Google Scholar profiles.

<span class="mw-page-title-main">Predatory publishing</span> Fraudulent business model for scientific publications

Predatory publishing, also write-only publishing or deceptive publishing, is an exploitative academic publishing business model, where the journal or publisher prioritizes self-interest at the expense of scholarship. It is characterized by misleading information, deviates from the standard peer review process, is highly non-transparent, and often utilizes aggressive solicitation practices.

<span class="mw-page-title-main">San Francisco Declaration on Research Assessment</span> 2012 manifesto against using the journal impact factor to assess a scientists work

The San Francisco Declaration on Research Assessment (DORA) is a statement that denounces the practice of correlating the journal impact factor to the merits of a specific scientist's contributions. Also according to this statement, this practice creates biases and inaccuracies when appraising scientific research. It also states that the impact factor is not to be used as a substitute "measure of the quality of individual research articles, or in hiring, promotion, or funding decisions".

<span class="mw-page-title-main">Vitek Tracz</span>

Vitek Tracz is a London-based entrepreneur who has been involved in science publishing, pharmaceutical information and mobile phone-based navigation.

<span class="mw-page-title-main">Shahid Jameel</span> Indian virologist and academic (born 1957)

Shahid Jameel is an Indian virologist and academic. Dr. Jameel is the Sultan Qaboos bin Said Fellow at Oxford Centre for Islamic Studies and Research Fellow, Green Templeton College, University of Oxford. He serves as the Principal Investigator for the Centre's project on Public Health, Science and Technology in Muslim societies. Previously he was the director of the Trivedi School of Biosciences since its inception in the year 2020 at Ashoka University. He was formerly head of the scientific advisory group to the Indian SARS-CoV-2 Genomics Consortia (INSACOG) established in December 2020, and the chief executive officer of Wellcome Trust DBT India Alliance. Known for his research in hepatitis E virus, Jameel is an elected fellow of all the three major Indian science academies viz. National Academy of Sciences, India, Indian Academy of Sciences, and Indian National Science Academy. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2000.

<span class="mw-page-title-main">Dipyaman Ganguly</span>

Dipyaman Ganguly is an Indian physician-scientist immunologist and cell biologist, currently a Principal Scientist and Swarnajayanthi Fellow at the CSIR-Indian Institute of Chemical Biology (IICB). He heads the Dendritic Cell Laboratory of IICB, popularly known as the Ganguly Lab, where he hosts several researchers involved in research on regulation of innate Immunity and pathogenesis of inflammatory disorders. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2022.

References

  1. 1 2 3 4 Allen, Elizabeth (29 September 2017). "A warm OA welcome to Richard Gallagher – Consulting Editor". ScienceOPEN.com. Retrieved 28 August 2020.
  2. 1 2 "Richard Gallagher". ORCID. 27 April 2020. Retrieved 28 August 2020.
  3. ↑ "Studies on cell adhesion in relation to immune responses". University of Glasgow. Retrieved 9 April 2021.
  4. ↑ Gallagher, Richard (7 September 2003). "Taking the Pulse of Scientific Societies". The Scientist. Retrieved 4 September 2020.
  5. ↑ "The Scientist names Richard Gallagher Editor". The Scientist. June 2002. Retrieved 28 August 2020.
  6. ↑ "Richard Gallagher". 10th World Conference of Science Journalism. 2017. Retrieved 28 August 2020.
  7. ↑ Maher, Brendan (7 October 2011). "The Scientist shutters after 25 years". Nature.com. Retrieved 10 September 2020.
  8. ↑ Fitzpatrick, Michael (2004). "8.6 Moving the goalposts". MMR and Autism. What Parents Need to Know. Routledge. p. 207. ISBN   1134355912.
  9. ↑ Stemwedel, Janet D. (29 June 2014). "Do permanent records of scientific misconduct findings interfere with rehabilitation?". Scientific American. Retrieved 10 September 2020.
  10. ↑ Smith, Tara (20 July 2006). "Gallagher gets it?". The Panda's Thumb . Retrieved 10 September 2010.
  11. ↑ Nisbet, Matthew W. (16 August 2010). "Richard Gallagher Steps Down as Editor of The Scientist". Big Think. Retrieved 28 August 2020.
  12. ↑ "Richard Gallagher joins 'cherished resource' Annual Reviews". Research Information. 4 February 2015. Retrieved 28 August 2020.
  13. ↑ "Annual Reviews Board of Directors". Annual Reviews.
  14. ↑ Brainard, Jeffrey (9 March 2020). "Publishers roll out alternative routes to open access". Science. Retrieved 4 September 2020.
  15. ↑ "Browse Journals". Annual Reviews. Retrieved 3 September 2020.
  16. ↑ Emerson, Eva; Gallagher, Richard (11 May 2018). "Putting the public in the know". Research Information. Retrieved 9 April 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.